hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Volunteer who agreed to participate in the study after signing a form of free and informed consent 2) Age between 20 and 70 years, 3) Systolic blood pressure between 140 and 179 mm Hg and diastolic blood pressure between 90 and 109 mm Hg, 4) Without clinical or biological signs of cardiovascular or renal hypertension (normal ECG, normal glomerular filtration rate and normal background of the eye), 5) Without any anti-hypertensive medication in progress (neither traditional nor modern).
Exclusion criteria
Exclusion criteria: 1)Rapid increase in BP requiring urgent drug treatment 2) Woman in a state of pregnancy or nursing 3) Use of drugs or other treatments (other than those of the study) that can significantly and permanently affect blood pressure, 4) Any major reaction observed during the study and requiring specific management after medical advice.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of blood pressure in a "plant" group equivalent to a "standard treatment" group and of at least 6 mmHg of systolic BP compared to the beginning of treatment, | — |
Secondary
| Measure | Time frame |
|---|---|
| Achievement of target value <= 140 / <= 90 to. Side effects | — |
Countries
Senegal
Contacts
prof